Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. 1987

R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron

Clonal chromosome abnormalities of 343 patients with de novo acute nonlymphocytic leukemia (ANLL) have been tentatively correlated with prognosis. All the patients were treated according to therapeutic protocols in the same hospital. The complete remission rate and median survival were generally lower in AA-ANLL (ANLL with only karyotypically abnormal metaphases) when compared with NN- and AN-ANLL. Similarly, AA-ANLL had the poorest prognosis in the majority of the classes of the French-American-British nomenclature. ANLL with inversion and/or deletion of chromosome #16 had the best prognosis, and ANLL with t(8;21) was not particularly favorable, nor was acute promyelocytic leukemia with t(15;17). ANLL with complex chromosomal abnormalities had the poorest prognosis. The conclusion is that chromosomal aberrations do have a prognostic significance in ANLL, but that this significance is dependent on the types of chromosomal aberrations.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
April 1982, Cancer genetics and cytogenetics,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
December 1991, Cancer genetics and cytogenetics,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
August 2019, Leukemia,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
December 1987, Seminars in oncology,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
January 1989, Blood,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
November 1981, The New England journal of medicine,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
January 2006, Asian Pacific journal of cancer prevention : APJCP,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
February 1988, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
August 1988, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
R Berger, and A Bernheim, and M E Ochoa-Noguera, and M T Daniel, and F Valensi, and F Sigaux, and G Flandrin, and M Boiron
February 1988, Leukemia,
Copied contents to your clipboard!